JP2010537671A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010537671A5 JP2010537671A5 JP2010524202A JP2010524202A JP2010537671A5 JP 2010537671 A5 JP2010537671 A5 JP 2010537671A5 JP 2010524202 A JP2010524202 A JP 2010524202A JP 2010524202 A JP2010524202 A JP 2010524202A JP 2010537671 A5 JP2010537671 A5 JP 2010537671A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- fragment
- monoclonal antibody
- seq
- chain variable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US19003407P | 2007-09-07 | 2007-09-07 | |
| USPCT/US2007/077942 | 2007-09-07 | ||
| US2007077942 | 2007-09-07 | ||
| US61/190,034 | 2007-09-07 | ||
| PCT/US2008/075488 WO2009033094A2 (en) | 2007-09-07 | 2008-09-05 | Antibodies and related molecules that bind to 24p4c12 proteins |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2010537671A JP2010537671A (ja) | 2010-12-09 |
| JP2010537671A5 true JP2010537671A5 (enExample) | 2011-06-16 |
| JP5518711B2 JP5518711B2 (ja) | 2014-06-11 |
Family
ID=40429722
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010524202A Active JP5518711B2 (ja) | 2007-09-07 | 2008-09-05 | ２４ｐ４ｃ１２タンパク質に結合する抗体および関連分子 |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP2185574B1 (enExample) |
| JP (1) | JP5518711B2 (enExample) |
| CA (1) | CA2698287A1 (enExample) |
| DK (1) | DK2185574T3 (enExample) |
| ES (1) | ES2424745T3 (enExample) |
| HR (1) | HRP20130649T1 (enExample) |
| PL (1) | PL2185574T3 (enExample) |
| PT (1) | PT2185574E (enExample) |
| WO (1) | WO2009033094A2 (enExample) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7244827B2 (en) * | 2000-04-12 | 2007-07-17 | Agensys, Inc. | Nucleic acid and corresponding protein entitled 24P4C12 useful in treatment and detection of cancer |
| WO2010022279A1 (en) * | 2008-08-20 | 2010-02-25 | Agensys, Inc. | Antibodies and related molecules that bind to 58p1d12 proteins |
| WO2010111018A1 (en) * | 2009-03-06 | 2010-09-30 | Agensys, Inc. | Antibody drug conjugates (adc) that bind to 24p4c12 proteins |
| SG194567A1 (en) | 2011-04-21 | 2013-12-30 | Seattle Genetics Inc | Novel binder-drug conjugates (adcs) and their use |
| AU2014372833B2 (en) | 2013-12-23 | 2019-08-22 | Bayer Pharma Aktiengesellschaft | Antibody drug conjugates (ADCs) with kinesin spindel protein (KSP) |
| HRP20220890T1 (hr) * | 2015-02-06 | 2022-10-14 | National University Of Singapore | Postupci za povećanje učinkovitosti terapijskih imunosnih stanica |
| SG11201710639YA (en) | 2015-06-22 | 2018-01-30 | Bayer Pharma AG | Antibody drug conjugates (adcs) and antibody prodrug conjugates (apdcs) with enzymatically cleavable groups |
| WO2017060322A2 (en) | 2015-10-10 | 2017-04-13 | Bayer Pharma Aktiengesellschaft | Ptefb-inhibitor-adc |
| SG10202008909VA (en) | 2016-03-24 | 2020-10-29 | Bayer Pharma AG | Prodrugs of cytotoxic active agents having enzymatically cleavable groups |
| WO2017216028A1 (en) | 2016-06-15 | 2017-12-21 | Bayer Pharma Aktiengesellschaft | Specific antibody-drug-conjugates (adcs) with ksp inhibitors and anti-cd123-antibodies |
| CN107841502A (zh) * | 2016-09-17 | 2018-03-27 | 复旦大学 | 核酸分子ctl4hsh1、其制备方法及应用 |
| CN107841500A (zh) * | 2016-09-18 | 2018-03-27 | 复旦大学 | 核酸分子ctl4hsh18、其制备方法及应用 |
| CN107841501A (zh) * | 2016-09-18 | 2018-03-27 | 复旦大学 | 核酸分子ctl4hsh20、其制备方法及应用 |
| CN107868782A (zh) * | 2016-09-26 | 2018-04-03 | 复旦大学 | 核酸分子ctl4hsh3、其制备方法及应用 |
| CN107868783A (zh) * | 2016-09-26 | 2018-04-03 | 复旦大学 | 核酸分子ctl4hsh2、其制备方法及应用 |
| CN107881171A (zh) * | 2016-09-30 | 2018-04-06 | 复旦大学 | 核酸分子ctl4hsh12、其制备方法及应用 |
| CN108070588A (zh) * | 2016-11-08 | 2018-05-25 | 复旦大学 | 核酸分子ctl4hsh8、其制备方法及应用 |
| CN118581046A (zh) | 2016-11-22 | 2024-09-03 | 新加坡国立大学 | 用于t细胞恶性肿瘤免疫疗法的cd7表达阻滞剂和嵌合抗原受体 |
| CN108118052A (zh) * | 2016-11-29 | 2018-06-05 | 复旦大学 | 核酸分子ctl4hsh17、其制备方法及应用 |
| US11433140B2 (en) | 2016-12-21 | 2022-09-06 | Bayer Pharma Aktiengesellschaft | Specific antibody drug conjugates (ADCs) having KSP inhibitors |
| AU2017380871C1 (en) | 2016-12-21 | 2025-05-15 | Bayer Aktiengesellschaft | Antibody drug conjugates (ADCs) having enzymatically cleavable groups |
| US12059472B2 (en) | 2016-12-21 | 2024-08-13 | Bayer Aktiengesellschaft | Prodrugs of cytotoxic active agents having enzymatically cleavable groups |
| CN108330128A (zh) * | 2017-01-17 | 2018-07-27 | 复旦大学 | 核酸分子ctl4hsh10、其制备方法及应用 |
| CA3071282A1 (en) | 2017-08-10 | 2019-02-14 | National University Of Singapore | T cell receptor-deficient chimeric antigen receptor t-cells and methods of use thereof |
| EP3553079A1 (en) * | 2018-04-12 | 2019-10-16 | Bayer Aktiengesellschaft | C-type natriuretic peptide engrafted antibodies |
| EP3553082A1 (en) | 2018-04-12 | 2019-10-16 | Bayer Aktiengesellschaft | Brain natriuretic peptide engrafted antibodies |
| EP3553081A1 (en) | 2018-04-12 | 2019-10-16 | Bayer Aktiengesellschaft | Atrial natriuretic peptide engrafted antibodies |
| JP7584299B2 (ja) | 2018-05-23 | 2024-11-15 | ナショナル ユニバーシティ オブ シンガポール | Ｔ細胞悪性腫瘍の免疫療法のためのｃｄ２表面発現の遮断およびキメラ抗原受容体の発現 |
| WO2024192280A2 (en) * | 2023-03-14 | 2024-09-19 | Mapp Biopharmaceutical, Inc. | Antibodies against orthohantaviruses |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI941572L (fi) | 1991-10-07 | 1994-05-27 | Oncologix Inc | Anti-erbB-2-monoklonaalisten vasta-aineiden yhdistelmä ja käyttömenetelmä |
| CA2372813A1 (en) | 1992-02-06 | 1993-08-19 | L.L. Houston | Biosynthetic binding protein for cancer marker |
| KR960702518A (ko) | 1993-05-17 | 1996-04-27 | 린다 에스, 스티븐슨 | Hiv 감염 및 aids에 대한 리보자임 유전자 치료(ribozyme gene therapy for hiv infection and aids) |
| IL112248A0 (en) | 1994-01-25 | 1995-03-30 | Warner Lambert Co | Tricyclic heteroaromatic compounds and pharmaceutical compositions containing them |
| US5747498A (en) | 1996-05-28 | 1998-05-05 | Pfizer Inc. | Alkynyl and azido-substituted 4-anilinoquinazolines |
| GB9520822D0 (en) | 1995-10-11 | 1995-12-13 | Wellcome Found | Therapeutically active compounds |
| GB9624482D0 (en) | 1995-12-18 | 1997-01-15 | Zeneca Phaema S A | Chemical compounds |
| AR007855A1 (es) | 1996-07-13 | 1999-11-24 | Glaxo Group Ltd | Compuestos heterociclicos fusionados como inhibidores de proteina tirosina quinasa, sus metodos de preparacion, intermediarios, uso en medicinay composiciones farmaceuticas que los contienen |
| HRP970371A2 (en) | 1996-07-13 | 1998-08-31 | Kathryn Jane Smith | Heterocyclic compounds |
| US6391874B1 (en) | 1996-07-13 | 2002-05-21 | Smithkline Beecham Corporation | Fused heterocyclic compounds as protein tyrosine kinase inhibitors |
| ID18494A (id) | 1996-10-02 | 1998-04-16 | Novartis Ag | Turunan pirazola leburan dan proses pembuatannya |
| CA2291709A1 (en) | 1997-05-30 | 1998-12-03 | Merck & Co., Inc. | Novel angiogenesis inhibitors |
| AU744939B2 (en) | 1997-09-26 | 2002-03-07 | Merck & Co., Inc. | Novel angiogenesis inhibitors |
| GB9800575D0 (en) | 1998-01-12 | 1998-03-11 | Glaxo Group Ltd | Heterocyclic compounds |
| RS49779B (sr) | 1998-01-12 | 2008-06-05 | Glaxo Group Limited, | Biciklična heteroaromatična jedinjenja kao inhibitori protein tirozin kinaze |
| US7109003B2 (en) * | 1998-12-23 | 2006-09-19 | Abgenix, Inc. | Methods for expressing and recovering human monoclonal antibodies to CTLA-4 |
| UA71945C2 (en) | 1999-01-27 | 2005-01-17 | Pfizer Prod Inc | Substituted bicyclic derivatives being used as anticancer agents |
| JP3270834B2 (ja) | 1999-01-27 | 2002-04-02 | ファイザー・プロダクツ・インク | 抗がん剤として有用なヘテロ芳香族二環式誘導体 |
| US6943235B1 (en) * | 1999-04-12 | 2005-09-13 | Agensys, Inc. | Transmembrane protein expressed in prostate cancer |
| EP1171595A1 (en) * | 1999-04-12 | 2002-01-16 | Agensys, Inc. | 13 transmembrane protein expressed in prostate cancer |
| AU2002352976B2 (en) * | 2002-11-27 | 2007-11-08 | Agensys, Inc. | Nucleic acid corresponding protein entitled 24P4C12 useful in treatment and detection of cancer |
-
2008
- 2008-09-05 EP EP08799268.1A patent/EP2185574B1/en active Active
- 2008-09-05 PL PL08799268T patent/PL2185574T3/pl unknown
- 2008-09-05 CA CA2698287A patent/CA2698287A1/en not_active Abandoned
- 2008-09-05 ES ES08799268T patent/ES2424745T3/es active Active
- 2008-09-05 HR HRP20130649AT patent/HRP20130649T1/hr unknown
- 2008-09-05 WO PCT/US2008/075488 patent/WO2009033094A2/en not_active Ceased
- 2008-09-05 PT PT87992681T patent/PT2185574E/pt unknown
- 2008-09-05 JP JP2010524202A patent/JP5518711B2/ja active Active
- 2008-09-05 DK DK08799268.1T patent/DK2185574T3/da active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20250333533A1 (en) | Macropinocytosing human anti-cd46 antibodies and targeted cancer therapeutics | |
| US12453780B2 (en) | Monoclonal antibodies specific for fibroblast growth factor receptor 4 (FGFR4) and methods of their use | |
| US12059474B2 (en) | Methods for selecting antibodies that specifically bind glycosylated immune checkpoint proteins | |
| CN103068851B (zh) | 内质蛋白的抗体及其用途 | |
| JP5781932B2 (ja) | 腫瘍抗原の生物活性を特異的にブロックする抗体 | |
| JP2008546780A5 (enExample) | ||
| EP3763388A1 (en) | Novel modulators and methods of use | |
| HRP20140171T1 (hr) | Protutijela i od njih izvedene molekule koje se vežu na steap-1-proteine | |
| AU2018250466A1 (en) | Novel modulators and methods of use | |
| JP2012507555A (ja) | 稀少疾患の治療における抗ｃｓ１抗体の使用 | |
| JP2006204290A5 (enExample) | ||
| US20080260740A1 (en) | Anti-LFL2 Antibodies for the Diagnosis, Prognosis and Treatment of Cancer | |
| JP2009197002A5 (enExample) | ||
| RU2010116184A (ru) | Новые антитела | |
| JP2006517109A5 (enExample) | ||
| HRP20170743T1 (hr) | Anti-ceacam5 protutijela i njihova uporaba | |
| JP2006517109A (ja) | アンフィレグリン抗体ならびに癌および乾癬を処置するためのその使用 | |
| WO2017023780A1 (en) | Antibody-drug conjugates for targeting cd56-positive tumors | |
| JP2010537671A (ja) | ２４ｐ４ｃ１２タンパク質に結合する抗体および関連分子 | |
| JP2013538042A5 (enExample) | ||
| JP2003523207A5 (enExample) | ||
| RU2007140311A (ru) | Антитела и родственные молекулы, связываюшиеся с белками 161p2f10b | |
| US20070020278A1 (en) | Diagnosing and treating cancer | |
| CN119013305A (zh) | 靶向gpc3的单克隆抗体和包含此抗体的抗体药物缀合物 | |
| RU2006146666A (ru) | Антитела и родственные молекулы, связывающиеся с белками psca |